Zojwalla Naseem — SEC Form 4 filings
SEC reporting owner CIK 1905871. 9 Form 4 filings on record with FilingPulse; latest filed 2026-02-04.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-01-29 to 2026-02-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 2 filings — 297,314 shares, $7,780,604 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
- Largest priced transaction: sale of 100,000 shares @ $28.04 ($2,804,000) in Olema Pharmaceuticals, Inc., filed 2025-12-23.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | CHIEF MEDICAL OFFICER | 9 | — | 7 legs · 297,314 sh · $7,780,604 | 21 |
Form 4 filings — Zojwalla Naseem
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-04 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/award (A): 250,000 (derivative) @ $0 · Grant/award (A): 106,250 (derivative) @ $0 | EDGAR |
| 2025-12-23 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Option exercise (M): 40,000 @ $15.25 · Sale (S): 57,079 @ $28.03 · Sale (S): 12,921 @ $28.93 · Option exercise (M): 42,818 @ $15.25 · Option exercise (M): 7,182 @ $7.02 · Sale (S): 100,000 @ $28.04 · +6 more | EDGAR |
| 2025-03-03 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/award (A): 205,000 (derivative) @ $0 | EDGAR |
| 2024-12-17 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Option exercise (M): 14,000 @ $4.87 · Option exercise (M): 14,000 (derivative) @ $0 | EDGAR |
| 2024-12-11 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/award (A): 52,000 @ $0 · Sale (S): 13,283 @ $9.37 · Sale (S): 14,202 @ $8.66 · Sale (S): 320 @ $9.39 | EDGAR |
| 2024-05-28 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Option exercise (M): 9,460 @ $4.87 · Option exercise (M): 9,460 (derivative) @ $0 | EDGAR |
| 2024-03-20 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Option exercise (M): 13,700 @ $4.87 · Option exercise (M): 13,700 (derivative) @ $0 | EDGAR |
| 2024-02-05 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/award (A): 195,000 (derivative) @ $0 | EDGAR |
| 2024-01-29 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Option exercise (M): 20,000 @ $7.02 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1905871 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →